On Feb 3, 2022 Dewpoint Therapeutics closed a Series C round and raised $150,000,000 from 3E Bioventures, ARCH Venture Partners, EcoR1 Capital, General Catalyst, Leaps […]
Series B – ConcertoCare
On Feb 3, 2022 ConcertoCare closed a Series B round and raised $105,000,000 from Deerfield Management, Obvious Ventures, Pennington Partners & Co, Schusterman Foundation, SteelSky […]
Series A – Getlabs
On Feb 3, 2022 Getlabs closed a Series A round and raised $20,000,000 from Anne Wojcicki, Byers Capital, Demetri Karagas, Emerson Collective, Eric Kinariwala, Healthworx, […]
Grant – Crohn’s and Colitis Canada
On Feb 3, 2022 Crohn’s and Colitis Canada closed a Grant round and raised $1,000,000 from Takeda Canada, featuring lead investors Takeda Canada. About the […]
Venture Round – Phylos
On Feb 1, 2022 Phylos closed a Venture – Series Unknown round and raised $7,600,000 from Accomplice, Entourage Effect Capital, Merida Capital Holdings, featuring lead […]
Venture Round – Talking Medicines
On Feb 1, 2022 Talking Medicines closed a Venture – Series Unknown round and raised £1,500,000 from Mark Bamforth, Scottish Enterprise, SIS Ventures, Tern, featuring […]
Venture Round – Phylos
On Feb 1, 2022 Phylos closed a Venture – Series Unknown round and raised $7,600,000 from Accomplice, Entourage Effect Capital, Merida Capital Holdings, featuring lead […]
Seed Round – Marigold Health
On Feb 1, 2022 Marigold Health closed a Seed round and raised $6,000,000 from Epsilon Health Investors, Felicis Ventures, Flare Capital Partners, KdT Ventures, SpringTide, […]
Series A – Jasper Health
On Feb 1, 2022 Jasper Health closed a Series A round and raised $25,000,000 from 7wire Ventures, General Catalyst, Human Capital, Redesign Health, W Health […]
Post-IPO Equity – Salona Global
On Jan 27, 2022 Salona Global closed a Post-IPO Equity round and raised $4,004,000 from investors, featuring lead investors . About the company: Salona Global […]
